待处理
入排:排除
图源:待检查
Corrigendum to 'Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival': [Annals of Oncology Volume 32, Issue 8, August 2021, Pages 1015-1024].
D J Slamon, P Neven, S Chia, G Jerusalem, M De Laurentiis, S Im, K Petrakova, G Valeria Bianchi, M Martín, A Nusch, G S Sonke, L De la Cruz-Merino, J T Beck, Y Ji, C Wang, U Deore, A Chakravartty, J P Zarate, T Taran, P A Fasching
Ann Oncol 32(10) 1307
摘要
摘要
无摘要
KM 提取结果
0 个 Figure · 0 个 KM 面板